FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DAVIS JAMES L
2. Issuer Name and Ticker or Trading Symbol

ProUroCare Medical Inc. [ PUMD ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

6446 FLYING CLOUD DR
3. Date of Earliest Transaction (MM/DD/YYYY)

10/31/2008
(Street)

EDEN PRAIRIE, MN 55344
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, $0.00001 par value                  180494   D    
Common stock, $0.00001 par value   10/31/2008     J (15)    6667   A $1.05   6667   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants   $5.00                     (1) 2/28/2010   Common stock, $0.00001 par value   15625     15625   D    
Warrants   $5.00                     (1) 3/21/2010   Common stock, $0.00001 par value   1702     1702   D    
Warrants   $5.00                     (1) 12/27/2012   Common stock, $0.00001 par value   5800     5800   D    
Warrants   $1.50                     (1) 4/2/2013   Common stock, $0.00001 par value   25000     25000   D    
Warrants   $5.00                     (1) 12/27/2012   Common stock, $0.00001 par value   6050     6050   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Warrants   $5.00                     (1) 12/27/2012   Common stock, $0.00001 par value   700     700   I   Held by "Davis & Associates Inc."   (2)
Warrants     (3)                   (4) 12/31/2012   Common stock, $0.00001 par value   30000     30000   D    
Warrants     (9)                   (4) 12/31/2012   Common stock, $0.00001 par value   30000     30000   D    
Warrants     (9)                   (4) 12/31/2012   Common stock, $0.00001 par value   10000     10000   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Warrants     (9)                   (4) 12/31/2012   Common stock, $0.00001 par value   5000     5000   I   Held by "Davis & Associates Inc."   (2)
10% Unsecured Convertible Subordinated Debenture     (7)                   (10) 2/16/2009   Common stock, $0.00001 par value   $200000   (8)   $200000   D    
Convertible Promissory Notes     (5)                   (5) 6/27/2009   Common stock, $0.00001 par value   $142500   (5)   $142500   D    
Convertible Promissory Notes     (6)                   (6) 6/27/2009   Common stock, $0.00001 par value   $142500   (6)   $142500   D    
Convertible Promissory Notes     (6)                   (6) 6/27/2009   Common stock, $0.00001 par value   $47500   (6)   $47500   I   Held by "Davis & Associates Inc. 401K PSP"   (2)
Convertible Promissory Notes     (6)                   (6) 6/27/2009   Common stock, $0.00001 par value   $23750   (6)   $23750   I   Held by "Davis & Associates Inc."   (2)
Call equivalent position     (11)                 9/16/2008   3/16/2009   (12) Notes and warrants   $50000     $0   D    
Warrant   $1.00                   9/16/2008   12/31/2012   Common stock, $0.00001 par value   10000     10000   D    
Warrants   $1.00                   9/24/2008   12/31/2012   Common stock, $0.00001 paar value   10000     10000   D    
Convertible Promissory Note     (12)                   (12) 3/16/2010   Common stock, $0.00001 par value   $47500   (12)   $47500   (12) D    
Convertible Promissory Note     (13)                   (13) 3/25/2010   Common stock, $0.00001 par value   $150000   (13)   $150000   (13) D    
Warrants   $1.50                   9/25/2008   9/25/2013   Common stock, $0.00001 par value   100000     100000   D    
Convertible Promissory Note     (14)                   (14) 12/31/2008   Common stock, $0.00001 par value   $37500   (14)   $37500   (14) D    
Warrants   $1                   10/28/2008   12/31/2012   Common stock, $0.00001 par value   10000     10000   D    
Convertible Promissory Notes     (12)                   (12) 3/16/2010   Common stock, $0.00001 par value   $47500   (12)   $47500   (12) D    
Warrants   $2.00   10/31/2008     (15)    16667       10/31/2009   10/31/2013   Common stock, $0.00001 par value   16667   $0   16667   D    

Explanation of Responses:
( 1)  Currently exercisable
( 2)  Reporting person is the Sole owner of Davis & Associates Inc. and has sole voting power.
( 3)  Each warrant is exercisable into common stock at 50% of the per share price of equity secutities issued in an underwritten public offering. In the event that the issuer fails to close a public offering prior to June 27, 2009, each warrant will be exercisable at 50% of the closing price of the issuer's common stock on that date.
( 4)  Each of the warrants will be exercisable upon the earlier of the closing of an underwritten public offering of the issuer's equity securities or June 27,2009.
( 5)  The Notes and accrued interest thereon automatically convert into common stock at 50% of the per share price of equity secutities issued in an underwritten public offering . If the issuer fails to close on an underwritten public offering by June 27, 2009 and fails to prepay the Notes, the Notes and the accrued interest thereon will convert into common stock at $0.05 per share.
( 6)  The Notes and accrued interest thereon automatically convert into common stock at 70% of the per share price of equity secutities issued in an underwritten public offering . If the issuer fails to close on an underwritten public offering by June 27, 2009 and fails to prepay the Notes, the Notes and the accrued interest thereon will convert into common stock at $0.05 per share.
( 7)  The principal amount and any accrued interest on the convertible debentures is convertible into common stock at $3.00 per share.
( 8)  Principal amount. Interest accrued at 10% and is convertible into common stock as well.
( 9)  Each warrant is exercisable into common stock at 70% of the per share price of equity secutities issued in an underwritten public offering. In the event that the issuer fails to close a public offering prior to June 27, 2009, each warrant will be exercisable at 70% of the closing price of the issuer's common stock on that date.
( 10)  Currently exercisable. The convertible debentures and any accrued interest thereon automatically convert into common stock upon the issuer's closing on an underwritten public offering.
( 11)  Pursuant to a Unit Put Agreement dated September 16, 2008, reporting person agreed to purchase up to $100,000 of Units, consisting of convertible notes with an aggregate principal amount of $95,000 and 20,000 warrants with an aggregate purchase price of $5,000. If and when the issuer gives notice to the reporting person of a closing, the reporting person is obligated to purchase his pro rata share of the total amount of Units to be sold at each closing by the issuer to persons who signed the Unit Put Agreement. The issuer's right to put Units to the reporting person expires on March 16, 2009. The convertible notes underlying the Units are convertible into shares of common stock and the warrants underlying the Units are exercisable for shares of common stock.
( 12)  On each of September 24, 2008 and October 28, 2008, the issuer closed on $50,000 of the reporting person's obligation to purchase the issuer's Units described in Footnote 11. In each closing, the reporting person purchased $47,500 of principal amount of convertible notes and warrants (with a purchase price of $2,500) to acquire 10,000 shares of common stock. These notes and accrued interest theron will automatically convert into common stock 30 days following the completion of an underwritten public offering by the issuer, at 70% of the per share price of equity secutities issued therein . If the issuer fails to close on an underwritten public offering by March 16, 2010 and fails to prepay these notes, the notes and the accrued interest thereon will convert into common stock at $0.15 per share.
( 13)  The reporting person loaned $150,000 to the issuer pursuant to a convertible promissory note. The note and accrued interest thereon will be convertible into common stock following the completion of an underwritten public offering by the issuer, at 70% of the per share price of equity secutities issued therein . The note and the accrued interest become due and payable if the issuer fails to close on an underwritten public offering by March 25, 2010, or if the holder chooses not to convert the note within 7 days following the completion of the public offering. The number of shares the note is convertible into will be determined upon the issuer's closing of an underwritten public offering.
( 14)  On September 12, 2008, the issuer amended an outstanding $37,500 promissory note with the reporting person to provide a conversion provision, such that the reporting person may convert the principal amount of the note and accrued interest into shares of the issuer's common stock following the completion of an underwritten public offering by the issuer, at 70% of the per share price of equity securities issued therein.
( 15)  Pursuant to a loan guarantee agreement dated Ocober 31, 2007, on October 31,2008, the issuer issued 6,667 shares of common stock and a five-year warrant to acquire 16,667 shares of common stock at $2.00 per share as consideration to the reporting person when the underlying loan was not paid off as of that date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DAVIS JAMES L
6446 FLYING CLOUD DR
EDEN PRAIRIE, MN 55344

X


Signatures
Richard B. Thon by power of attorney 11/4/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more ProUroCare Medical (CE) Charts.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more ProUroCare Medical (CE) Charts.